XML 50 R3.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Loss and Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Expenses    
Accretion $ 4,184,390 $ 445,190
Amortization and depreciation 1,679,471 380,336
General administrative costs 4,916,760 4,914,547
Impairment of mineral properties 1,537,822
Professional fees 6,770,793 2,203,163
Promotion and shareholder communication 184,579 287,887
Travel 410,242 312,236
Transfer agent and filing fees 944,817 322,792
Staff costs 10,675,267 4,130,741
Stock option expense 4,538,747 5,744,655
Loss from operations (35,842,888) (18,741,547)
Foreign exchange (loss) (2,210,492) (58,456)
Gain (loss) on change in asset retirement obligation estimate 221,185 (157,227)
Gain on divestment of mineral properties 10,091,565 1,624,049
Gain on sale of uranium investment 2,575,500 35,000
Interest expense (3,532,029) (2,556)
Interest income 393,347 406,132
Loss on investment in associates (586,900)
Loss on write-off of sales tax recoverable (91,289)
Unrealized gain on marketable securities 5,917,835 1,057,405
Net loss for the year (22,385,977) (16,515,389)
Currency translation adjustment of subsidiaries 2,414,123 (665,809)
Comprehensive loss for the year $ (19,971,854) $ (17,181,198)
Weighted average number of common shares outstanding    
- basic # (in Shares) 144,043,709 105,529,292
- diluted # (in Shares) 144,043,709 105,529,292
Basic and diluted loss per share $ (in Dollars per share) $ (0.16) $ (0.16)
Diluted loss per share $ (in Dollars per share) $ (0.16) $ (0.16)